NCT02619877View on ClinicalTrials.gov

Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

October 31, 2016

Conditions
Diabetic Foot Ulcer
Interventions
BIOLOGICAL

ALLO-ASC-DFU

Application of ALLO-ASC-DFU sheet to diabetic foot ulcer

OTHER

Standard therapy

Standard therapy conducted for patients with diabetic foot ulcer

Trial Locations (4)

08308

Korea University Guro Hospital, Guro-gu

01830

Eulji General Hospital, Nowon-Gu

03722

Severance Hospital, Seodaemun-Gu

05505

Asan medical center, Songpa-Gu

All Listed Sponsors
lead

Anterogen Co., Ltd.

INDUSTRY

NCT02619877 - Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter